PET/CT for the characterization of adrenal masses in patients with cancer: Qualitative versus quantitative accuracy in 150 consecutive patients

American Journal of Roentgenology

Volumn 192, Issue 4, 2009, Pages 956-962

  Boland, Giles W L ^a   Blake, Michael A ^a   Holalkere, Nagaraj S ^a   Hahn, Peter F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adrenal masses; Nonfunctioning adenomas; Oncologic imaging; PET CT; Standardized uptake ratio; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADRENAL TUMOR; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; RADIODENSITOMETRY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; TUMOR VOLUME;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63849099807     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1431     Document Type: Article

References (29)

1. Young WF Jr. The incidentally discovered adrenal mass. N Engl J Med 2007; 356:601-610
2. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR 2008; 190:1163-1168
3. Mansmann G, Lau J, Blak E, et al. The clinically inapparent adrenal mass: update in diagnosis and treatment. Endocr Rev 2004; 25:309-340
4. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008; 249:756-775
5. Lee MJ, Hahn PF, Papanicolau N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415-418
6. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonade-nomas using CT attenuation values. AJR 1996; 166:531-536
7. Korobkin M. CT characterization of adrenal masses: the time has come. Radiology 2000; 217: 629-632
8. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined un-enhanced and delayed enhanced CT. Radiology 2002; 222:629-633
9. Mitchell DG, Crovello M, Matteucci T, Peterson RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351
10. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses(> 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995; 165:91-95
11. Mayo-Smith WW, Boland GW, Noto RB, et al. State-of-the-art adrenal imaging. RadioGraphics 2001; 21:995-1012
12. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy- D-glucose. Radiology 1995; 194:131-134
13. 18F-fluorodeoxyglucose positron emission tomography. AJR 1997; 168: 1357-1360
14. Gupta NC, Graeber GM, Tamim WJ, Rogers JS, Irisari L, Bishop HA. Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer. Clin Lung Cancer 2001; 3:59-64
15. Maurea S, Klain M, Mainolfi C, Ziviello M, Sal-vatore M. The diagnostic role of radionuclide imaging in evaluation of patients with nonhyperse-creting adrenal masses. J Nucl Med 2000; 42: 884-892
16. 18F-FDG positron emission tomography scanning. Int J Clin Pract 2007; 61: 802-809
17. Frilling A, Tecklenborg K, Weber F, et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 2004; 136:1289-1296
18. Kumar R, Xiu Y, Yu JQ, et al. 18-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004; 45:2058-2062
19. Elaini AB, Shetty SK, Chapman VM, et al. Improved detection and characterization of adrenal disease with PET-CT. RadioGraphics 2007; 27: 755-767
20. Chong S, Lee KS, Kim AH. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. RadioGraphics 2006; 26:1811-1826
21. Blake MA, James MA, Slattery JM, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 2006; 238:970-977
22. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 2006; 47:32-37
23. Park BK, Kim CK, Kim B, Choi JY. Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients. J Comput Assist Tomogr 2007; 31:550-556
24. Caoili EM, Korobkin M, Brown RKJ, Mackie G, Shulkin BL. Differentiating adrenal adenomas from nonadenomas using 18-F-FDG PET/CT: quantitative and qualitative evaluation. Acad Ra-diol 2007; 14:468-475
25. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998; 171:201-204
26. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995; 36:1836-1839
27. Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 2004; 45:1431-1434
28. Boellaard R, Krak NC, Hoekstra OS, Lammerts- ma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004; 45: 1519-1527
29. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001; 42:1795-1799